Peter Mitchell

Peter Mitchell supports the Army Medical Resources Acquisition Activity under the Defense Health Agency, managing complex acquisitions to advance military medical readiness through the procurement of advanced biomedical, diagnostic, and laboratory technologies. He plays a pivotal role in securing cutting-edge analytical instrumentation, pharmaceutical preparations, and clinical research capabilities essential to sustaining the operational health of U.S. Army personnel. His portfolio emphasizes high-performance scientific equipment and life sciences innovation, ensuring that field medical units and research facilities are equipped with mission-critical technologies aligned with DoD strategic priorities. Mitchell maintains enduring partnerships with leading contractors including CHENEGA Professional & Technical Services LLC, SNA International LLC, MABEAL GmbH, Canon Medical Informatics Inc., and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. These relationships span technical services, medical device integration, laboratory automation, and biomedical research support, reflecting a preference for established vendors with proven expertise in defense-critical life sciences domains. His contracting approach prioritizes technical capability, regulatory compliance, and sustained performance over short-term cost savings. His procurement patterns show a strong emphasis on open competition, with 72.7% of awards issued without set-asides, while still maintaining a meaningful commitment to small business participation through Total Small Business Set-Asides (18.2%) and 8(a) competed awards (9.1%). This balanced strategy ensures access to innovative solutions while fostering socioeconomic diversity in the supplier base. Mitchell’s primary NAICS focus lies in Analytical Laboratory Instrument Manufacturing (40%), followed by Pharmaceutical Preparation Manufacturing (20%) and Research and Development in the Life Sciences (10%). He routinely procures mass spectrometers, clinical diagnostics platforms, automated lab systems, and specialized reagents, demonstrating deep technical familiarity with biomedical engineering, laboratory infrastructure modernization, and translational medical research. His expertise ensures acquisitions align with the Army’s evolving needs in precision medicine and battlefield health readiness.